Paul F. Engstrom Receives Lifetime Achievement Award for Cancer Prevention

Paul F. Engstrom, MD, FACP
Paul F. Engstrom, MD, FACP

PHILADELPHIA (March 13, 2018) - Paul F. Engstrom, MD, FACP, Samuel M.V. Hamilton Chair in Cancer Prevention and special adviser to the president at Fox Chase Cancer Center, has been selected to receive the Prevent Cancer Foundation’s Laurels Award for Lifetime Achievement in Cancer Prevention.

With more than 50 years as an oncologist, including more than 45 at Fox Chase,

Engstrom has a long history of successful leadership in cancer prevention and early detection. In 1979 at Fox Chase, he established the first cancer prevention and control program at an NCI-designated cancer center, and he has served as the principal investigator for several cancer prevention and screening research programs. Engstrom’s projects include the Early Detection Research Network, which focused on breast and ovarian cancer screening and diagnosis. He is also a founding member of the National Comprehensive Cancer Network Patient Guideline Committee, and is known globally as a spokesperson for the national guidelines on screening, diagnosis, management, and patient support.

“Dr. Engstrom is a true leader in cancer prevention, here at Fox Chase and around the world. We congratulate him on receiving this lifetime achievement award and look forward to all that he will continue to accomplish,” said Richard I. Fisher, president and CEO at Fox Chase Cancer Center.

The Prevent Cancer Foundation is a non-profit organization that focuses on funding cancer prevention research, education, and advocacy and outreach programs across the country. It is the only organization in the U.S. that focuses its advocacy efforts solely on cancer prevention, early detection, and screening. The Foundation started the Cancer Prevention Laurels in 2003, to honor distinguished individuals who have made a significant and lasting impact in the field of cancer prevention, with an emphasis on early detection and screening. Recipients of the award are nominated by their peers.

Engstrom will receive the award at the Foundation’s 2018 Dialogue for Action Conference in Tysons, Virginia on April 12.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427